{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:38:39Z","timestamp":1770338319212,"version":"3.49.0"},"reference-count":36,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T00:00:00Z","timestamp":1625961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Concurrent opioid and benzodiazepine (BZD) use is a prevalent high\u2010risk prescribing behavior that increases the risk of opioid overdose. However, there is limited evidence on the relationship between timing of concurrent use and risk of opioid overdose.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the likelihood of opioid\u2010related overdose across levels of duration, recency, and daily dose of concurrent use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A nested case\u2010control study was conducted using Truven MarketScan claims data (2009\u20132018).<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Commercially insured adults (age 18\u201364\u00a0years old) with a new opioid dispensing in 2010\u20132018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Measures<\/jats:title><jats:p>Cases of opioid\u2010related overdose were identified based on hospitalization diagnosis codes. Controls were matched to cases in a 10:1 ratio by age, sex, opioid start date, and cancer history. Concurrent use was classified based on duration, timing, and daily dose of overlapping opioids and BZDs during 90\u00a0days before the event. Conditional logistic regression models were used to evaluate the relationship between concurrent use and opioid\u2010related overdose.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p>Among 11,137,866 dispensed a new opioid, a total of 3388 patients experienced opioid\u2010related overdose and were matched to 33,893 controls. Cases and controls were 34\u00a0years old on average and 54% female. Patients with concurrent use were significantly more likely to have opioid\u2010related overdose compared to patients receiving opioids, BZDs, or neither (OR 9.28; 95% CI 7.87, 10.93). Longer concurrent use of 1\u20137, 8\u201330, and 31\u201390\u00a0days was associated with 4.6, 12.1, and 26.7\u2010fold higher likelihood of opioid\u2010related overdose (<jats:italic>p\u00a0<\/jats:italic>&lt;\u00a00.01). Patients with overlapping prescriptions during previous 0\u201330, 31\u201360, and 61\u201390\u00a0days were 13.2, 6.0, and 3.2\u2010times more likely to experience an overdose (<jats:italic>p\u00a0<\/jats:italic>&lt;\u00a00.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with an opioid\u2010related overdose were more likely to be prescribed concurrent opioid and BZD across all levels of duration, timing, and daily dose. Future policies and quality measures should be pursued to prevent concurrent use unless medically necessary.<\/jats:p><\/jats:sec>","DOI":"10.1002\/phar.2608","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T11:29:24Z","timestamp":1624620564000},"page":"722-732","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hospitalizations for opioid\u2010related overdose and timing of concurrent opioid and benzodiazepine use: A nested case\u2010control study"],"prefix":"10.1002","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0720-7894","authenticated-orcid":false,"given":"Ali","family":"Alobaidi","sequence":"first","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy College of Pharmacy University of Illinois at Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-7091","authenticated-orcid":false,"given":"A. Simon","family":"Pickard","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy College of Pharmacy University of Illinois at Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-308X","authenticated-orcid":false,"given":"Jennie B.","family":"Jarrett","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice College of Pharmacy University of Illinois at Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-5367","authenticated-orcid":false,"given":"Todd A.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy College of Pharmacy University of Illinois at Chicago Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,7,11]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3182a95d86"},{"key":"e_1_2_10_3_1","unstructured":"Centers for Disease Control and Prevention.U.S. Opioid Dispensing Rate Maps 2020.https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxrate\u2010maps.html. Accessed 01\/08\/2021."},{"key":"e_1_2_10_4_1","first-page":"1","article-title":"Physician office visits at which benzodiazepines were prescribed: findings from 2014\u20132016 National Ambulatory Medical Care Survey","volume":"137","author":"Santo L","year":"2020","journal-title":"Natl Health Stat Rep"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.370"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102020\u2010038692"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.8325"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2361"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j760"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0919"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2698"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010019\u201005545\u2010y"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.2.169"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001111"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.117"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.03.040"},{"key":"e_1_2_10_18_1","unstructured":"Concurrent use of opioids and benzodiazepines.2019.http:\/\/pqaalliance.org\/measures\/default.asp. Accessed June 25 2019."},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15767"},{"key":"e_1_2_10_20_1","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999\u20132017","volume":"329","author":"Hedegaard H","year":"2018","journal-title":"NCHS Data Brief"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2004.014472"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4872"},{"key":"e_1_2_10_23_1","volume-title":"CDC Compilation of Benzodiazepines, Muscle Relaxants, Stimulants, Zolpidem, and Opioid Analgesics with Oral Morphine Milligram Equivalent Conversion Factors, 2018 Version","author":"Control NCfIPa","year":"2018"},{"key":"e_1_2_10_24_1","unstructured":"SP. K. ClinCalc: Benzodiazepine Equivalents Conversion Calculator.2017."},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1514387"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/ajp.0000000000000643"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.10.010"},{"key":"e_1_2_10_29_1","volume-title":"Multivariate data analysis","author":"Hair JF","year":"1998"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201900446"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.2793"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13273"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnw140"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/adm.0000000000000354"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1904190"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny307"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.05.001"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2608","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/phar.2608","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:44:34Z","timestamp":1761054274000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,11]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1002\/phar.2608"],"URL":"https:\/\/doi.org\/10.1002\/phar.2608","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,11]]},"assertion":[{"value":"2021-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}